Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

Kyung Dong Pharmaceutical Revenue

Kyung Dong Pharmaceutical had revenue of 47.81B KRW in the quarter ending March 31, 2026, with 4.37% growth. This brings the company's revenue in the last twelve months to 198.27B, up 1.86% year-over-year. In the year 2025, Kyung Dong Pharmaceutical had annual revenue of 196.27B with 1.20% growth.

• Revenue (ttm): 198.27B
• Revenue Growth: +1.86%
• P/S Ratio: 0.69
• Revenue / Employee: 566.50M
• Employees: 350
• Market Cap: 136.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	196.27B	2.34B	1.20%
Dec 31, 2024	193.94B	31.26B	19.22%
Dec 31, 2023	162.67B	-20.04B	-10.97%
Dec 31, 2022	182.72B	5.11B	2.88%
Dec 31, 2021	177.61B	3.78B	2.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error